Sangamo Therapeutics (SGMOQ) Times Interest Earned (2011 - 2025)

Sangamo Therapeutics' Times Interest Earned history runs 15 years deep, the most recent figure standing at -$0.09 for Q4 2025.

• On a quarterly basis, Times Interest Earned fell 28.71% year-over-year to -$0.09 in Q4 2025; TTM through Dec 2025 was -$0.29, a 2.11% decrease from a year earlier, with the FY2025 full-year figure at -$0.29, down 2.11% from the prior year.
• Times Interest Earned fell to -$0.09 in Q4 2025 per SGMOQ's latest filing, from -$0.07 in the prior quarter.
• Across five years, Times Interest Earned topped out at $46.12 in Q1 2023 and bottomed at -$2086.4 in Q3 2023.
• The 5-year median for Times Interest Earned is -$25.35 (2021), against an average of -$187.25.
• Biggest YoY gain for Times Interest Earned was 240.22% in 2023; the steepest drop was 5266.78% in 2023.
• Year by year, Times Interest Earned stood at -$23.47 in 2021, then slumped by 733.96% to -$195.73 in 2022, then jumped by 99.91% to -$0.18 in 2023, then surged by 59.96% to -$0.07 in 2024, then retreated by 28.71% to -$0.09 in 2025.
• Per Business Quant, the three latest SGMOQ Times Interest Earned figures stand at -$0.09 (Q4 2025), -$0.07 (Q4 2024), and -$0.18 (Q4 2023).